Register Cart 0

Generic placeholder image

Current Neuropharmacology

Editor-in-Chief

ISSN (Print): 1570-159X
ISSN (Online): 1875-6190

Back Subscribe

Editorial

Parkinson´s and Alzheimer´s Diseases and Natural Products: Pathologies and Medication of the New Times

Author(s): Seyed Mohammad Nabavi* and Eduardo Sobarzo-Sánchez*

Volume 19, Issue 2, 2021

Published on: 31 December, 2020

Page: [112 - 113] Pages: 2

DOI: 10.2174/1570159X1902201231153120

« Previous Next »

Rights & Permissions Print Export Cite as

Article Metrics

7

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

For Visitors

International No Diet Day

Related Articles

3D MI-DRAGON: New Model for the Reconstruction of US FDA Drug- Target Network and Theoretical-Experimental Studies of Inhibitors of Rasagiline Derivatives for AChE
Current Topics in Medicinal Chemistry

Establishing Genomic/Transcriptomic Links Between Alzheimer’s Disease and Type 2 Diabetes Mellitus by Meta-Analysis Approach
CNS & Neurological Disorders - Drug Targets

CoMFA, CoMSIA and HQSAR Studies of Acetylcholinesterase Inhibitors
Current Computer-Aided Drug Design

Modification of Lifestyle Factors are Needed to Improve the Metabolic Health of Patients with Cardiovascular Disease Risk
Current Pharmaceutical Design

Subclinical Hypothyroidism and Cognitive Dysfunction in the Elderly
Endocrine, Metabolic & Immune Disorders - Drug Targets

Hypoxic Preconditioning Ameliorates Amyloid-β Pathology and Longterm Cognitive Decline in AβPP/PS1 Transgenic Mice
Current Alzheimer Research

Anti-HIV Drug Distribution to the Central Nervous System
Current Pharmaceutical Design

(Pro)renin Receptor as a New Drug Target
Current Pharmaceutical Design

Beneficial Neurobiological Effects of Melatonin Under Conditions of Increased Oxidative Stress
Current Medicinal Chemistry - Central Nervous System Agents

Melatonin and Regulation of Immune Function: Impact on Numerous Diseases
Current Aging Science

Current & Future Therapies of Erectile Dysfunction in Neurological Disorders
Recent Patents on CNS Drug Discovery (Discontinued)

Pathophysiology of Diabetic Secondary Complication and their Management
Current Diabetes Reviews

Effects of Cholinesterase Inhibitors on the Activities and Protein Levels of Cholinesterases in the Cerebrospinal Fluid of Patients with Alzheimers Disease: A Review of Recent Clinical Studies
Current Alzheimer Research

Cognition in Non-Demented Diabetic Older Adults
Current Aging Science

Chemical Composition and Inhibitory Effects of Hypericum brasiliense and H. connatum on Prolyl Oligopeptidase and Acetylcholinesterase Activities
Medicinal Chemistry

Current Evaluation of the Millennium Phytomedicine- Ginseng (II): Collected Chemical Entities, Modern Pharmacology, and Clinical Applications Emanated from Traditional Chinese Medicine
Current Medicinal Chemistry

Mitogenomics: Recognizing the Significance of Mitochondrial Genomic Variation for Personalized Medicine
Current Pharmacogenomics and Personalized Medicine

Nerve Growth Factor: Structure, Function and Therapeutic Implications for Alzheimers Disease
Current Drug Targets - CNS & Neurological Disorders

Functional Relevance of Biased Signaling at the Angiotensin II Type 1 Receptor
Endocrine, Metabolic & Immune Disorders - Drug Targets

Cognitive Consequences of a Sustained Monocyte Type 1 IFN Response in HIV-1 Infection
Current HIV Research

© 2023 Bentham Science Publishers | Privacy Policy